The Proteasome Inhibitor PS-341 (Bortezomib) Up-Regulates DR5 Expression Leading to Induction of Apoptosis and Enhancement of TRAIL-Induced Apoptosis Despite Up-Regulation of c-FLIP and Survivin Expression in Human NSCLC Cells
Liu X(Shandong University), Shi‐Yong Sun(Emory University)
Cited by 164
Related Papers
Enhancing Mammalian Target of Rapamycin (mTOR)–Targeted Cancer Therapy by Preventing mTOR/Raptor Inhibition-Initiated, mTOR/Rictor-Independent Akt Activation
|Cancer Research|2008|159
DDIT3 and KAT2A Proteins Regulate TNFRSF10A and TNFRSF10B Expression in Endoplasmic Reticulum Stress-mediated Apoptosis in Human Lung Cancer Cells
|Journal of Biological Chemistry|2015|127
The deubiquitinase USP22 regulates PD-L1 degradation in human cancer cells
|Cell Communication and Signaling|2020|115
Proteasome Inhibitor PS-341 (Bortezomib) Induces Calpain-dependent IκBα Degradation
|Journal of Biological Chemistry|2010|98
Rictor Undergoes Glycogen Synthase Kinase 3 (GSK3)-dependent, FBXW7-mediated Ubiquitination and Proteasomal Degradation
|Journal of Biological Chemistry|2015|98